Trastuzumab Charge Variants: a Study on Physicochemical and Pharmacokinetic Properties

被引:0
|
作者
Torkashvand, Fatemeh [1 ]
Mehranfar, Mahsa [1 ]
Gero, Mahsa Rashidi [1 ,2 ]
Jafarian, Parisa [1 ,3 ]
Mirabzadeh, Esmat [1 ]
Azarian, Bahareh [1 ]
Sardari, Soroush [1 ]
Vaziri, Behrouz [1 ,4 ]
机构
[1] Pasteur Inst Iran, Biotechnol Res Ctr, Tehran, Iran
[2] Islamic Azad Univ, Dept Biol, Sci & Res Branch, Tehran, Iran
[3] Islamic Azad Univ, Fac Biol Sci, Dept Biochem, North Tehra branch, Tehran, Iran
[4] Pasteur Inst Iran, Biotechnol Res Ctr, 69,Pasteur St, Tehran 1316943551, Iran
关键词
Monoclonal antibodies; Pharmacokinetics; Trastuzumab; MONOCLONAL-ANTIBODIES; IN-VITRO; HETEROGENEITY; RECOMBINANT; BINDING; IDENTIFICATION; DEAMIDATION;
D O I
暂无
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Background: Post-translational modifications in bioprocessing and storage of recombinant mAbs are the main sources of charge variants. While the profile of these kinds of variants is considered an important quality attribute of therapeutic mAbs, there is controversy about their direct role on safety and efficacy. In this study, the physicochemical and PK properties of separated charge variants belonging to a trastuzumab potential biosimilar were examined.Methods: The APs, BPs, and main variants of trastuzumab were separated and enriched by semi-preparative WCX. A panel of analytical techniques was utilized to characterize the physicochemical properties of these variants. The binding affinity to HER2 and Fc gamma Rs and the PK parameters were evaluated for each variant.Results: Based on the results, the charge variants of the proposed biosimilar had no significant influence on the examined efficacy and PK parameters.Conclusion: During the development and production of biosimilar mAbs, studying the effects of their charge variants on efficacy and PK parameters is needed. DOI: 10.52547/ibj.3837
引用
收藏
页码:108 / 116
页数:9
相关论文
共 50 条
  • [1] Physicochemical and functional characterization of trastuzumab-dkst, a trastuzumab biosimilar
    Goyal, Parag
    Iyer, Jyoti
    Adhikary, Laxmi
    Vats, Bhavesh
    Kabadi, Pradeep
    Pai, Harish
    Ranayhossaini, Daniel
    Gouda, Shankara
    Subbarao, Malini
    Mehta, Gaurav
    Saha, Arindam
    Bera, Arnab
    Sahu, Abhilashi
    Kaur, Maninder
    Singh, Ankita
    Marwah, Ashwani
    Reddy Moole, Praveen Kumar
    Smith, Jeffrey
    Melarkode, Ramakrishnan
    Ullanat, Rajesh
    FUTURE MEDICINAL CHEMISTRY, 2021, 13 (18) : 1531 - 1557
  • [2] Pharmacokinetic Comparability of a Biosimilar Trastuzumab Anticipated from Its Physicochemical and Biological Characterization
    Miranda-Hernandez, Mariana P.
    Lopez-Morales, Carlos A.
    Pina-Lara, Nelly
    Perdomo-Abundez, Francisco C.
    Perez, Nestor O.
    Revilla-Beltri, Jorge
    Molina-Perez, Aaron
    Estrada-Marin, Larisa
    Flores-Ortiz, Luis F.
    Ruiz-Argueelles, Alejandro
    Medina-Rivero, Emilio
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [3] Optimisation of the use of sliding window deconvolution for comprehensive characterisation of trastuzumab and adalimumab charge variants by native high resolution mass spectrometry
    Millan-Martin, Silvia
    Carillo, Sara
    Fussl, Florian
    Sutton, Jennifer
    Gazis, Paul
    Cook, Ken
    Scheffler, Kai
    Bones, Jonathan
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2021, 158 : 83 - 95
  • [4] Bioprocess Challenges in Purification of Therapeutic Protein Charge Variants
    Gupta, Tarun
    Kumar, Anuj
    Seshadri, Sriram
    BIOTECHNOLOGY AND BIOPROCESS ENGINEERING, 2023, 28 (04) : 493 - 506
  • [5] 2D-CEX-FcRn-MS to Study Structure/Function Relation of mAb Charge Variants
    Verscheure, Liesa
    Vandenheede, Isabel
    De Rore, Eline
    Meersseman, Mabelle
    Hanssens, Valerie
    Meerschaert, Kris
    Stals, Hilde
    Sandra, Pat
    Lynen, Frederic
    Borgions, Filip
    Sandra, Koen
    ANALYTICAL CHEMISTRY, 2024, 96 (45) : 18122 - 18131
  • [6] Physicochemical and Biological Characterization of a Biosimilar Trastuzumab
    Lopez-Morales, Carlos A.
    Miranda-Hernandez, Mariana P.
    Carmina Juarez-Bayardo, L.
    Ramirez-Ibanez, Nancy D.
    Romero-Diaz, Alexis J.
    Pina-Lara, Nelly
    Campos-Garcia, Victor R.
    Perez, Nestor O.
    Flores-Ortiz, Luis F.
    Medina-Rivero, Emilio
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [7] Development of a Mass Spectrometric Method for Pharmacokinetic Study of Trastuzumab
    Hong, Nam Young
    Choi, Jin Nyoung
    Kang, Jeong Won
    Choi, Do Young
    Park, Gyu-Tae
    Kim, Kwang Pyo
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2014, 35 (06) : 1845 - 1847
  • [8] Similarity demonstrated between isolated charge variants of MB02, a biosimilar of bevacizumab, and Avastin® following extended physicochemical and functional characterization
    Ruppen, Isabel
    Beydon, Marie-Elise
    Solis, Clea
    Sacristan, Daniel
    Vandenheede, Isabel
    Ortiz, Alexia
    Sandra, Koen
    Adhikary, Laxmi
    BIOLOGICALS, 2021, 73 : 41 - 56
  • [9] Similarity demonstrated between isolated charge variants of MB02, a biosimilar of bevacizumab, and Avastin® following extended physicochemical and functional characterization
    Ruppen, Isabel
    Beydon, Marie-Elise
    Solis, Clea
    Sacristan, Daniel
    Vandenheede, Isabel
    Ortiz, Alexia
    Sandra, Koen
    Adhikary, Laxmi
    BIOLOGICALS, 2022, 77 : 1 - 15
  • [10] Assessing the Impact of Charge Variants on Stability and Viscosity of a High Concentration Antibody Formulation
    Sule, Shantanu V.
    Fernandez, Jason E.
    Mecozzi, Vincent J.
    Kravets, Yana
    Yang, William C.
    Feng, Pamela
    Liu, Suli
    Zang, Li
    Capili, Allan D.
    Estey, Tia B.
    Gupta, Kapil
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 106 (12) : 3507 - 3514